OUT OF MIND
Would you like to react to this message? Create an account in a few clicks or log in to continue.
Latest topics
» Ghislaine Maxwell Put on 'Suicide' Watch amid 'Recent Development'
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyToday at 4:50 pm by PurpleSkyz

» Dave Schmidt- new scam - he will buy the Dong currency for you!
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 8:19 pm by RamblerNash

» Elon Musk's AI humanoid robot to be unveiled in September
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 10:05 am by PurpleSkyz

» Putin announces new BRICS global reserve currency project to REPLACE the petrodollar
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 10:02 am by PurpleSkyz

» ‘Psi & Science’, Why Do Some Scientists Refuse To Consider The Evidence For Psi Phenomena?
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 9:59 am by PurpleSkyz

» Shots for Tots Rollout Flops in NYC
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 9:56 am by PurpleSkyz

» As Thousands of Its Members Remain Unvaccinated, Navy Replaces Weekly Updates With Monthly Reports
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 9:53 am by PurpleSkyz

» Cameras Capture Biden’s Cheat Sheet Showing Hilarious Instructions: ‘YOU Take YOUR Seat’
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 9:02 am by PurpleSkyz

» FDA “Approves” COVID Vaccine for 6-month-old Babies Despite 179K Deaths Within 60 Days of Vaccination in England Alone
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 8:37 am by PurpleSkyz

»  ‘The End of Germ Theory’ Documentary
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 8:34 am by PurpleSkyz

» Chaos in Los Angeles as Violent Riots Over Roe v. Wade Being Overturned plus MORE
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 8:19 am by PurpleSkyz

» Pentagon Wants to Use Elon Musk’s SpaceX Vessels as Assault Starships
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyYesterday at 8:11 am by PurpleSkyz

» UFO NEWS ~ Two fighter jets chasing a UFO over Mount Desert Island in Maine plus MORE
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 9:46 am by PurpleSkyz

» Rare Sky Event - June 24th, 2022
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 8:42 am by PurpleSkyz

» Reactivation of Chickenpox Virus Following COVID-19 Injections on the Rise
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 8:31 am by PurpleSkyz

»  Polio Virus Has Been Detected in London's Sewage
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 8:27 am by PurpleSkyz

» Pilots and troops saw '11,500mph craft' over Brazil
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 8:23 am by PurpleSkyz

» Ayahuasca and the Endocannabinoid System
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 8:05 am by PurpleSkyz

» US Supreme Court Declines Bayer/Monsanto Bid to Challenge Glyphosate Cancer Rulings
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 8:01 am by PurpleSkyz

» Antarctica: You're free to go there....you're not allowed to go there!
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 7:43 am by PurpleSkyz

» Ashley Bidens Diary Should Be Used as Evidence in Criminal Trial
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 7:37 am by PurpleSkyz

» YIKES! Anti-vax nurse injects 8,600 with saline instead of COVID vaccine
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? EmptyFri Jun 24, 2022 7:31 am by PurpleSkyz

You are not connected. Please login or register

OUT OF MIND » BREAKING NEWS & HOT TOPICS » PLANDEMICS » Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin?

Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin?

Go down  Message [Page 1 of 1]

PurpleSkyz

PurpleSkyz
Admin

Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin?


In his latest video, John Campbell, Ph.D., compared ivermectin, whose use as a COVID treatment has been widely criticized by mainstream media, with Merck’s new COVID drug, Molnupiravir, which is garnering positive media coverage.

By 
  Jeremy Loffredo  

Link copied
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin? Dr-John-Campbell-Ivermectin-Molnupiravir-feature-800x417


The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It's free.
In his latest video, John Campbell, Ph.D., compared ivermectin, whose use as a COVID treatment has been widely criticized by mainstream media, with Merck’s new COVID drug, Molnupiravir, which has been the subject of glowing media attention.
Campbell, a UK-based nurse teacher, cited several studies as he compared the two treatments on the basis of effectiveness, safety and cost. He first turned to a paper in the Austin Journal of Pharmacology and Therapeutics, “Drugs Shown to Inhibit SARS-Cov-2 in COVID-19 Disease: Comparative Basic and Clinical Pharmacology of Molnupiravir and Ivermectin.”
The peer-reviewed paper refers to ivermectin as the most studied “repurposed” medication globally, and notes that it is approved by the U.S. Food and Drug Administration and “classified by the World Health Organization (WHO) as an ‘essential’ broad spectrum antiparasitic, antibiotic, and has demonstrated broad antiviral activity against RNA viruses, including HIV, Zika, MERS and coronavirus.”
“And of course, ivermectin also won the Nobel Prize in 2015,” Campbell said.

ORDER TODAY: Robert F. Kennedy, Jr.'s New Book — 'The Real Anthony Fauci'  
According to the paper, Campbell said, Molnupiravir — though still going through trials and safety testing — is believed to “work against seasonal and pandemic flu, MERS, coronavirus and SARS-CoV-2.” The paper’s author noted that Molnupiravir does not inhibit inflammation, whereas ivermectin does.
How do the two drugs compare on cost? Ivermectin is exponentially cheaper than Merck’s new Molnupiraravir.
The cost of a complete five-day course of Molnupiravir is $700 — or $70 per pill. That amounts to a 4,000% markup over what it costs Merck to make the drug.
Citing 2013 prices provided by the WHO, Campbell said a five-day course of ivermectin — 10 3mg pills — costs $0.53. (However, at today’s U.S. prices, 10 3mg pills cost about $39).
On effectiveness, Molnupiravir is lacking data. The only publicly available clinical data on Molnupiravir comes from a Merck press statement claiming the new drug is 50% effective against hospitalizations and deaths, when used as an early treatment.
For ivermectin, using publicly available data, Campbell referred to one peer-reviewed study that pegs ivermectin’s effectiveness in early treatment at 62%, and an ongoing meta-analysis which shows ivermectin is 66% effective in early treatment and 86% effective as a prophylactic.
Using VigiBase, a WHO database on pharmaceutical safety data, Campbell showed that out of  3.7 billion doses given of ivermectin there have been only 5,693 reports of adverse events — far fewer, according to Campbell, than the number of adverse event reports associated with amoxicillin and ibuprofen, both widely used and considered safe.
Comparable safety information for Merck’s Molnupiravir is not yet available, as trials and studies are still ongoing. But Campbell did raise concern about  Molnupiravir’s mutagenic properties. He cited the Austin Journal of Pharmacology and Therapeutics paper which states, “there is some concern about the safety of [Molnupiravir’s] NHC-nucleoside triphosphate, which is mutagenic to mammalian cells.”
According to Campbell, Merck denies this is a problem. But the paper suggests, at the very least,” it needs looking into,” Campbell said.
Watch the video here:




https://youtu.be/hKa3EZqofNo


https://childrenshealthdefense.org/defender/john-campbell-mercks-covid-molnupiravir-ivermectin/?utm_source=salsa&eType=EmailBlastContent&eId=9c55c2a0-1637-40fb-b6bc-d63cf27fef44
Thanks to: https://childrenshealthdefense.org



  

Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum